Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Wakefield

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Cancer Treatment and Research|January 1, 1992
Roles for transforming growth factors-beta in the genesis, prevention, and treatment of breast cancerL M Wakefield, A A Colletta, B K McCune, et al.
Growth Factors (Chur, Switzerland)|January 1, 1990
Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3P D Brown, L M Wakefield, A D Levinson, et al.
Growth Factors (Chur, Switzerland)|January 1, 1991
Addition of a C-terminal extension sequence to transforming growth factor-beta 1 interferes with biosynthetic processing and abolishes biological activityL M Wakefield, P Kondaiah, R S Hollands, et al.
Cancer Research|January 4, 1998
Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthraceneE P Böttinger, J L Jakubczak, D C Haines, et al.
Princess Takamatsu Symposia|January 1, 1989
Transforming growth factor-beta and suppression of carcinogenesisM B Sporn, A B Roberts, L M Wakefield, et al.
The Journal of Cell Biology|August 1, 1987
Distribution and modulation of the cellular receptor for transforming growth factor-betaL M Wakefield, D M Smith, T Masui, et al.
Cytokine & Growth Factor Reviews|August 7, 2009
TGF-beta3 and cancer: a reviewH G Laverty, L M Wakefield, N L Occleston, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Transforming growth factor-beta: multifunctional regulator of cell growth and phenotypeL M Wakefield, N L Thompson, K C Flanders, et al.
The Journal of Clinical Investigation|January 1, 1991
The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor betaA A Colletta, L M Wakefield, F V Howell, et al.
Growth Factors (Chur, Switzerland)|January 1, 1989
Recombinant TGF-beta 1 is synthesized as a two-component latent complex that shares some structural features with the native platelet latent TGF-beta 1 complexL M Wakefield, D M Smith, S Broz, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Cancer Treatment and Research|January 1, 1992
Roles for transforming growth factors-beta in the genesis, prevention, and treatment of breast cancerL M Wakefield, A A Colletta, B K McCune, et al.
Growth Factors (Chur, Switzerland)|January 1, 1990
Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3P D Brown, L M Wakefield, A D Levinson, et al.
Growth Factors (Chur, Switzerland)|January 1, 1991
Addition of a C-terminal extension sequence to transforming growth factor-beta 1 interferes with biosynthetic processing and abolishes biological activityL M Wakefield, P Kondaiah, R S Hollands, et al.
Cancer Research|January 4, 1998
Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthraceneE P Böttinger, J L Jakubczak, D C Haines, et al.
Princess Takamatsu Symposia|January 1, 1989
Transforming growth factor-beta and suppression of carcinogenesisM B Sporn, A B Roberts, L M Wakefield, et al.
The Journal of Cell Biology|August 1, 1987
Distribution and modulation of the cellular receptor for transforming growth factor-betaL M Wakefield, D M Smith, T Masui, et al.
Cytokine & Growth Factor Reviews|August 7, 2009
TGF-beta3 and cancer: a reviewH G Laverty, L M Wakefield, N L Occleston, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Transforming growth factor-beta: multifunctional regulator of cell growth and phenotypeL M Wakefield, N L Thompson, K C Flanders, et al.
The Journal of Clinical Investigation|January 1, 1991
The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor betaA A Colletta, L M Wakefield, F V Howell, et al.
Growth Factors (Chur, Switzerland)|January 1, 1989
Recombinant TGF-beta 1 is synthesized as a two-component latent complex that shares some structural features with the native platelet latent TGF-beta 1 complexL M Wakefield, D M Smith, S Broz, et al.
Pageof 7